17:18 , Dec 16, 2016 |  BC Week In Review  |  Company News

Protalix sales and marketing update

Protalix said the Brazilian Ministry of Health issued a letter requesting three shipments of alfataliglicerase to treat Type I Gaucher disease. The company estimated the revenues from the shipments to be about $24 million. The...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

iBio, General Electric, FIOCRUZ biomanufacturing news

General Electric's GE Healthcare business and iBio will design a plant-based manufacturing facility for the foundation's Bio-Manguinhos unit in Brazil. The project is the first contract under a 2012 deal between GE Healthcare and iBio...
07:00 , Apr 23, 2012 |  BC Week In Review  |  Company News

Bill & Melinda Gates Foundation genitourinary, infectious news

The Brazilian Ministry of Health partnered with the Bill & Melinda Gates Foundation to fund and launch research in Brazil to improve the health of women and children. The partners will launch Grand Challenges Brazil...
01:06 , Apr 17, 2012 |  BC Extra  |  Politics & Policy

Brazil, Gates partner for health initiative

The Brazilian Ministry of Health partnered with the Bill & Melinda Gates Foundation to fund and launch research in Brazil to improve the health of women and children. The partners will launch Grand Challenges Brazil...
08:00 , Nov 14, 2011 |  BC Week In Review  |  Company News

Bristol-Myers, Brazilian Ministry of Health deal

Bristol-Myers signed a tech transfer agreement with the Brazilian Ministry of Health to expand Brazil's access to BMS's HIV drug Reyataz atazanavir. The state owned Farmanguinhos laboratory will have rights to manufacture and distribute the...
01:26 , Nov 12, 2011 |  BC Extra  |  Company News

BMS, Brazil in HIV tech transfer agreement

Bristol-Myers Squibb Co. (NYSE:BMY) signed a tech transfer agreement with the Brazilian Ministry of Health to expand the country's access to BMS's HIV drug Reyataz atazanavir. The state owned Farmanguinhos laboratory will have exclusive rights...
07:00 , Jun 21, 2010 |  BioCentury  |  Strategy

Playing Brazil

Brazil is often mentioned as a major emerging market for biopharmaceutical companies, with annual pharmaceutical growth rates forecast to be 7-10% in the coming years. But most drug sales come from generics - including copies...
07:00 , Oct 5, 2009 |  BC Week In Review  |  Company News

GlaxoSmithKline, Brazilian Ministry of Health infectious news

GlaxoSmithKline received an eight-year, €1.5 billion ($2.2 billion) contract to supply the ministry with Synflorix pediatric pneumococcal vaccine for 13 million children annually. Each vaccination requires 2-4 doses. The price per dose will start at...
07:00 , Aug 24, 2009 |  BC Week In Review  |  Company News

GlaxoSmithKline, Brazilian Ministry of Health deal

The Brazilian Ministry of Health 's Oswaldo Cruz Foundation and GlaxoSmithKline partnered to develop and increase access to new vaccines. GSK will establish an R&D program at the foundation to develop a dengue fever vaccine....
07:00 , Jul 4, 2005 |  BC Week In Review  |  Company News

Abbott infectious news

On June 24, the Brazilian Ministry of Health gave ABT 10 days to reduce the price of its Kaletra lopinavir/ritonavir for HIV, or the government will grant a compulsory license to a generic manufacturer, which...